Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
241,740,891
-
Share change
-
+2,119,716
-
Total reported value
-
$9,197,380,535
-
Put/Call ratio
-
35%
-
Price per share
-
$38.02
-
Number of holders
-
552
-
Value change
-
+$22,972,972
-
Number of buys
-
227
-
Number of sells
-
317
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q3 2022
As of 30 Sep 2022,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
552 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
241,740,891 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, Boston Partners, Fisher Asset Management, LLC, BANK OF AMERICA CORP /DE/, BlackRock Inc., Camber Capital Management LP, MORGAN STANLEY, Invesco Ltd., and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
561
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.